![Cancer Chemo- and Immunopharmacology [electronic resource] : 2: Immunopharmacology, Relations, and General Problems /](/search/themes/bootstrap3/images/libros.png)
Cancer Chemo- and Immunopharmacology [electronic resource] : 2: Immunopharmacology, Relations, and General Problems /
Tumor-Specific Antigens -- Autoreactive Cells as Mediators of the Natural Defense Against Malignant Tumors -- Progress in Experimental Systemic Active Immunotherapy of Cancer -- Host’s Immune State and Kinetics of Local Tumor Growth Control — Progression of Postoperative Lung Metastasis -- Immunotherapy Versus Chemotherapy of Acute Myeloid Leukemia: Response to PHA, Allogeneic Lymphocytes, and Leukemic Myeloblasts of Remission Lymphocytes from Leukemia Patients -- Suppressor Cells in Hodgkin’s Disease and Lung Carcinoma -- Immune Imbalance in Cancer Patients -- Immunorestoration of Anergic Cancer Patients by Azimexon -- BCG Versus VCN: The Antigenicity and the Adjuvant Effect of Both Compounds -- Differences in Chemotherapeutic Susceptibility of Human T-, B-, and Non-T-/Non-B-Lymphocytes in Culture -- The Significance of Lectin Receptors in the Kidney and in Hypernephroma (Renal Adenocarcinoma) -- Specific Immunotherapy of Acute Lymphoid Leukemia Patients by REH Cell Line -- Results of Postoperative Treatment of Colorectal Cancer by Radiotherapy, Chemotherapy and Immunotherapy -- Some “Pharmacologic” Data About Corynebacterium Parvum -- Increased Resistance to Tumor Graft in Mice Infected by Vaccinal Strains of Brucella Abortus -- Thymosin: Basic Properties and Clinical Application in the Treatment of Immunodeficiency Diseases and Cancer -- One or Several Thymic Hormones? -- Ability of Thymosin to Decrease in Vivo and in Vitro Suppressor Cell Activity in Tumor Bearing Mice and Cancer Patients -- Screening of Small Molecular Microbial Products Modulating Immune Responses and Bestatin -- A Review of Clinical Studies of Bestatin -- Bestatin Treatment and the Peripheral Lymphocyte Population in Cancer Patients -- Correction of Immunodeficiency in Aged Mice by Levamisole and Bestatin Administration -- Therapeutic Effects of BM 12,531 (Prop. INN Azimexon) -- In Vivo Immunomodulating Properties of Two Synthetic Agents: Azimexon and Tuftsin -- Effects of BM 12,531 (Azimexon) on in Vitro Lymphocyte and Macrophage Proliferation -- Comparative Evaluation of the Tumor Inhibitory and Antibacterial Activity of Solubilized and Particulate Glucan -- Mechanism of the Inhibitory Effect of Levan on Experimental Tumors -- Lynestrenol: A Progesterone like Agent with Immunostimulatory Properties -- Chemotherapy Immunogenicity -- Selective Imbalances of Cellular Immune Responses by Adriamycin -- The Heterogeneity of the Interaction Between Cancer Chemotherapeutic Agents and Host Resistance Mechanisms -- Endotoxin-Induced Tumor Necrosis Factor -- Antimicrobial Resistance Enhancing Activity of Tumor Necrosis Serum Factor Induced by Endotoxin in BCG-TreatedMice -- Tumor-Necrotizing Serum Production by Administration of BCG + Pseudomonas: Its Application in Treatment of Fibrosarcoma in Mice -- Usefulness of the Results of Studies on the Antitumor Effects of Interferon in Animals to Interferon-Therapy of Patients -- DNA, Liposomes, and Proteins as Carriers for Antitumoral Drugs -- Antibodies as Carriers for Oncostatic Materials -- Pulmonary Localization of Intravenously Injected Liposomes -- Erythrocytes and Lymphocytes as Drug Carrier Systems: Techniques for Entrapment of Drugs in Living Cells -- Chemo- and Immunopharmacology: The Reality and the Horizons of Cancer Treatment.
| Main Authors: | , , |
|---|---|
| Format: | Texto biblioteca |
| Language: | eng |
| Published: |
Berlin, Heidelberg : Springer Berlin Heidelberg,
1980
|
| Subjects: | Medicine., Pharmacy., Pharmacology., Oncology., Biomedicine., Pharmacology/Toxicology., |
| Online Access: | http://dx.doi.org/10.1007/978-3-642-81491-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Tumor-Specific Antigens -- Autoreactive Cells as Mediators of the Natural Defense Against Malignant Tumors -- Progress in Experimental Systemic Active Immunotherapy of Cancer -- Host’s Immune State and Kinetics of Local Tumor Growth Control — Progression of Postoperative Lung Metastasis -- Immunotherapy Versus Chemotherapy of Acute Myeloid Leukemia: Response to PHA, Allogeneic Lymphocytes, and Leukemic Myeloblasts of Remission Lymphocytes from Leukemia Patients -- Suppressor Cells in Hodgkin’s Disease and Lung Carcinoma -- Immune Imbalance in Cancer Patients -- Immunorestoration of Anergic Cancer Patients by Azimexon -- BCG Versus VCN: The Antigenicity and the Adjuvant Effect of Both Compounds -- Differences in Chemotherapeutic Susceptibility of Human T-, B-, and Non-T-/Non-B-Lymphocytes in Culture -- The Significance of Lectin Receptors in the Kidney and in Hypernephroma (Renal Adenocarcinoma) -- Specific Immunotherapy of Acute Lymphoid Leukemia Patients by REH Cell Line -- Results of Postoperative Treatment of Colorectal Cancer by Radiotherapy, Chemotherapy and Immunotherapy -- Some “Pharmacologic” Data About Corynebacterium Parvum -- Increased Resistance to Tumor Graft in Mice Infected by Vaccinal Strains of Brucella Abortus -- Thymosin: Basic Properties and Clinical Application in the Treatment of Immunodeficiency Diseases and Cancer -- One or Several Thymic Hormones? -- Ability of Thymosin to Decrease in Vivo and in Vitro Suppressor Cell Activity in Tumor Bearing Mice and Cancer Patients -- Screening of Small Molecular Microbial Products Modulating Immune Responses and Bestatin -- A Review of Clinical Studies of Bestatin -- Bestatin Treatment and the Peripheral Lymphocyte Population in Cancer Patients -- Correction of Immunodeficiency in Aged Mice by Levamisole and Bestatin Administration -- Therapeutic Effects of BM 12,531 (Prop. INN Azimexon) -- In Vivo Immunomodulating Properties of Two Synthetic Agents: Azimexon and Tuftsin -- Effects of BM 12,531 (Azimexon) on in Vitro Lymphocyte and Macrophage Proliferation -- Comparative Evaluation of the Tumor Inhibitory and Antibacterial Activity of Solubilized and Particulate Glucan -- Mechanism of the Inhibitory Effect of Levan on Experimental Tumors -- Lynestrenol: A Progesterone like Agent with Immunostimulatory Properties -- Chemotherapy Immunogenicity -- Selective Imbalances of Cellular Immune Responses by Adriamycin -- The Heterogeneity of the Interaction Between Cancer Chemotherapeutic Agents and Host Resistance Mechanisms -- Endotoxin-Induced Tumor Necrosis Factor -- Antimicrobial Resistance Enhancing Activity of Tumor Necrosis Serum Factor Induced by Endotoxin in BCG-TreatedMice -- Tumor-Necrotizing Serum Production by Administration of BCG + Pseudomonas: Its Application in Treatment of Fibrosarcoma in Mice -- Usefulness of the Results of Studies on the Antitumor Effects of Interferon in Animals to Interferon-Therapy of Patients -- DNA, Liposomes, and Proteins as Carriers for Antitumoral Drugs -- Antibodies as Carriers for Oncostatic Materials -- Pulmonary Localization of Intravenously Injected Liposomes -- Erythrocytes and Lymphocytes as Drug Carrier Systems: Techniques for Entrapment of Drugs in Living Cells -- Chemo- and Immunopharmacology: The Reality and the Horizons of Cancer Treatment. |
|---|